相关产品推荐更多 >

Research Grade Capromab(Biosimilar 抗体), 研究级Capromab(Biosimilar 抗体)
¥2288
Vibostolimab Biosimilar Anti-TIGIT, VSIG9, VSTM3 mAb (Research Grade), Vibostolimab生物类似药 抗TIGIT, VSIG9, VSTM3单抗 (研究级)
¥1186
Urelumab Biosimilar Anti-TNFRSF9, CD137 mAb (Research Grade), Urelumab生物类似药 抗TNFRSF9, CD137单抗 (研究级)
¥1186
Figitumumab Biosimilar Anti-IGF1R, CD221 mAb (Research Grade), Figitumumab生物类似药 抗IGF1R, CD221单抗 (研究级)
¥1186
Emibetuzumab Biosimilar Anti-MET, RCCP2 mAb (Research Grade), Emibetuzumab生物类似药 抗MET, RCCP2单抗 (研究级)
¥1186
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AI 赋能培养基定制开发:CHO 培养基是如何实现产量提升Cytoscape 教程来了!快速实现顶刊同款通路网络图五大应用案例:Mustang Q 膜层析应用全解析1 个小工具,一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 抗体名:
Research Grade Anti-HIV1 gp41 Antibody (10E8#)
- 抗体英文名:
Research Grade Anti-HIV1 gp41 Antibody (10E8#)
- 靶点:
type 1 group M subtype B (isolate HXB2)(HIV-1)
- 浓度:
1.44 mg/ml
- 应用范围:
Research Grade Biosimilar
- 宿主:
Human
- 适应物种:
abinScience
- 保质期:
1 year
- 抗原来源:
Human
- 目录编号:
1 year
- 级别:
Human
- 库存:
VK617116
- 供应商:
999
- 克隆性:
Monoclonal
- 保存条件:
0.01M PBS, pH 7.4.
- 形态:
Liquid
- 亚型:
IgG
| Product name | Research Grade Anti-HIV1 gp41 Antibody (10E8#) |
| Host species | Human |
| Clonality | Monoclonal |
| Target | gp41/Glycoprotein 41 |
| Species reactivity | type 1 group M subtype B (isolate HXB2)(HIV-1) |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Concentration | 1.44 mg/ml |
| Form | Liquid |
| Isotype | IgG |
| Immunogen | \ |
| Applications | Research Grade Biosimilar |
| Brand | abinScience |
| CAT. | VK617116 |
| Expiration date | 1 year |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Yeast IF without Dehydration--酵母免疫荧光(无甲醇脱水方法)
Note :this protocol is a modified version of the protocol from Mark Rose in the CSH Yeast Genetics Course Manual. Grow cells at the appropriate temperature to 5x10E6 in 5 mls YPD. Add 0.5mls 37% formaldehyde (best grade) and incubate
Nature重磅技术TransTAC选中的受体!TFR1这个铁转运蛋白要火了
generation." Biochemical and biophysical research communications 471.3 (2016): 373-379. [31] Martínez;nez, Laura E., et al. "Targeting TfR1 with the ch128. 1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV+ Human Primary
.: AR3A, human anti‐HCV E2 antibody (Law et al., ) E910, mouse anti‐HCV NS5A antibody (Lindenbach et al
技术资料暂无技术资料 索取技术资料





